Home › Non-Small Cell Lung Cancer › North Carolina › Charlotte
Pag-aaral pangklinika para sa Non-Small Cell Lung Cancer sa Charlotte, NC
19 pag-aaral para sa Non-Small Cell Lung Cancer ang naghahanap ng mga kalahok sa mga site sa loob at paligid ng Charlotte (sa loob ng humigit-kumulang 30 milya). Buksan ang pag-aaral upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Nagre-recruitPhase 3
- Novant Health Weisiger Cancer Insititute ( Site 0266), Charlotte
Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
Nagre-recruitPhase 3
- Carolinas Medical Center, Charlotte
Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy
Nagre-recruitPhase 2
- Levine Cancer Institute, Charlotte
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
Nagre-recruitPhase 2
- Atrium Health, Charlotte
Pan-tumor MRD Study
Nagre-recruitObservasyonal na pag-aaral
- Carolina Oncology Specialists, Charlotte
Quick Start Durvalumab Following Chemoradiation for Stage III Nonsmall Cell Lung Cancer
Nagre-recruitPhase 2
- Atrium Health Levine Cancer, Charlotte
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
Nagre-recruitPhase 1/2
- Carolina Biooncology Institute, Huntersville · 13 mi ang layo
Beamion LUNG-3: Adjuvant Zongertinib vs Standard Treatment in People With Completely Resected Stage II-IIIB NSCLC Harboring Activating HER2 TKD Mutations
Nagre-recruitPhase 3
- Levine Cancer Institute, Charlotte
Safety and Preliminary Effectiveness of BNT317, an Investigational Therapy for Advanced Solid Tumors
Nagre-recruitPhase 1/2
- Carolina BioOncology Institute, LLC, Huntersville · 13 mi ang layo
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
Nagre-recruitPhase 1/2
- Levine Cancer Institute - Charlotte, Charlotte
Cancer-related Fatigue During Maintenance Immunotherapy for Non-small Cell Lung Cancer (NSCLC): a Qualitative Study
Nagre-recruitObservasyonal na pag-aaral
- Atrium Health Levine Cancer, Charlotte
A Study to Evaluate ARV-6723 Alone and With Pembrolizumab in Participants With Advanced Solid Tumors
Nagre-recruitPhase 1/2
- Clinical Trial Site, Huntersville · 13 mi ang layo
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
Nagre-recruitPhase 1
- Carolina BioOncology Institute /ID# 232597, Huntersville · 13 mi ang layo
Study of XB010 in Subjects With Solid Tumors
Nagre-recruitPhase 1
- Carolina BioOncology Institute, Huntersville · 13 mi ang layo
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Nagre-recruitPhase 1
- Carolina BioOncology Institute, Huntersville · 13 mi ang layo
Dose Escalation/Expansion Study of Mavrostobart (PT199), an Anti-CD73 mAb, Administered Alone and in Combination With a PD-1 Inhibitor or Chemotherapy (the MORNINGSTAR Study)
Nagre-recruitPhase 1/2
- Carolina BioOncology Institute, Huntersville · 13 mi ang layo
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
Nagre-recruitObservasyonal na pag-aaral
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- Atrium Health Pineville/LCI-Pineville, Charlotte
- Levine Cancer Institute-SouthPark, Charlotte
- at 8 pa
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
Nagre-recruitPhase 1/2
- Carolina BioOncology Institute, Huntersville · 13 mi ang layo
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Nagre-recruitPhase 1
- Dren Investigational Site, Huntersville · 13 mi ang layo
Pag-aaral para sa Non-Small Cell Lung Cancer sa ibang lungsod
- Houston, TX145 pag-aaral
- New York City, NY121 pag-aaral
- Arlington, VA104 pag-aaral
- Nashville, TN97 pag-aaral
- Boston, MA90 pag-aaral
- Los Angeles, CA87 pag-aaral
- St. Louis, MO73 pag-aaral
- Chicago, IL61 pag-aaral
- Baltimore, MD60 pag-aaral
- San Antonio, TX59 pag-aaral
- Columbus, OH57 pag-aaral
- Washington, DC55 pag-aaral
Iba pang pag-aaral sa Charlotte
- Kanser (lahat ng uri)27 pag-aaral
- Kanser sa Suso22 pag-aaral
- Multiple Myeloma21 pag-aaral
- Acute Myeloid Leukemia16 pag-aaral
- Obesity16 pag-aaral
- Overweight15 pag-aaral
- Colorectal Cancer13 pag-aaral
- Kanser sa Ovary12 pag-aaral
- Pagkabigo ng Puso11 pag-aaral
- Metastatic Cancer11 pag-aaral
- Squamous Cell Carcinoma ng Ulo at Leeg10 pag-aaral
- COPD9 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.